CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Shares withheld for taxes SENIOR VICE PRESIDENT AND CFO gave up 1,461 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - NEW BUS DEV & SPEC SALES gave up 5,566 shares (to pay taxes)
- 4 Grant or award SVP OPS & PROD DEV acquired 32,041 shares (grant or award)
- 4 Grant or award SENIOR VICE PRESIDENT AND CFO acquired 54,470 shares (grant or award)
- 4 Grant or award PRESIDENT & CEO acquired 136,495 shares (grant or award)
- 4 Grant or award Director acquired 9,292 shares (grant or award)
- 4 Grant or award Director acquired 9,292 shares (grant or award)
- 4 Grant or award Director acquired 9,292 shares (grant or award)
- 4 Grant or award Director acquired 9,292 shares (grant or award)
- 4 Grant or award Director acquired 9,292 shares (grant or award)
- 4 Grant or award Director acquired 9,292 shares (grant or award)
- 4 Open-market buy Director bought 4,000 shares at $32.89 ($131,555)
- 4 Grant or award CHIEF COMMERCIAL OFFICER acquired 16,134 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award SVP, GENERICS acquired 12,907 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000 shares at $25.96 ($129,800)
- 4 Grant or award PRESIDENT & CEO acquired 28,508 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CHAIRMAN, INTERIM PRES. & CEO bought 10,000 shares at an average $30.78 ($307,790)
Page 18 of 42 · 835 filings